Paper7307620
Aerosol penetration into the lung; influence on airway responses.
Dolovich M and 2 others. Chest, 1981. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Aerosol penetration into the lung; influence on airway responses. Papers, record 7307620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7307620
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aerosols | Major topic |
| Respiratory System | Major topic |
| Bronchi | |
| Bronchodilator Agents | |
| Forced Expiratory Volume | |
| Histamine | |
| Humans | |
| Lung Diseases, Obstructive | |
| Particle Size |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33424258 | Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases. | Saudi Pharm J | 2020 | https://conductscience.org/library/papers/33424258 | PubMed |
| 25762449 | Pharmacokinetics of Orally Inhaled Drug Products. | AAPS J | 2015 | https://conductscience.org/library/papers/25762449 | PubMed |
| 22619512 | Inhaled chemotherapy in lung cancer: future concept of nanomedicine. | Int J Nanomedicine | 2012 | https://conductscience.org/library/papers/22619512 | PubMed |
| 18181531 | In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review. | AAPS PharmSciTech | 2007 | https://conductscience.org/library/papers/18181531 | PubMed |
| 14616419 | Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. | Br J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/14616419 | PubMed |
| 14616418 | Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. | Br J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/14616418 | PubMed |
| 9155849 | The science of nebulised drug delivery. | Thorax | 1997 | https://conductscience.org/library/papers/9155849 | PubMed |
| 8439931 | Aerosol therapy in Canada: what are the standards? | CMAJ | 1993 | https://conductscience.org/library/papers/8439931 | PubMed |
| 8299656 | Aerosols for therapy and diagnosis. | Eur J Nucl Med | 1993 | https://conductscience.org/library/papers/8299656 | PubMed |
| 6364444 | Effect of prior bronchoconstriction on the airway response to histamine in normal subjects. | Thorax | 1984 | https://conductscience.org/library/papers/6364444 | PubMed |
| 3226182 | Generation of a submicrometre nicotine aerosol for inhalation. | Med Biol Eng Comput | 1988 | https://conductscience.org/library/papers/3226182 | PubMed |
| 3208783 | Investigation into the effect of Fenoterol on mucociliary clearance in patients with chronic bronchitis. | Eur J Nucl Med | 1988 | https://conductscience.org/library/papers/3208783 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7307620
GET https://conductscience.org/api/papers/v1/7307620/authors